Lecture 5_020824 PDF
Document Details
Uploaded by RemarkableAwe3867
Department of Pharmacognosy and Herbal Medicine
Tags
Related
- Viral Replication And Antiviral Targets Past Paper PDF January 2024
- Viral Replication and Antiviral Targets MCQs PDF
- Virology Lecture Notes (2023/2024) - Sinai University - PDF
- Lecture 8: Prevention and Treatment of Viral Infections PDF
- ANTİVİRALLER EN SON PDF
- Acquired Immunodeficiencies Session 27 PDF
Summary
This lecture covers general characteristics of viruses, including their structure and multiplication. It also discusses various antiviral medications and antimicrobial resistance.
Full Transcript
GENERAL CHARACTERISTICS OF VIRUSES Viruses contain a single type of nucleic acid (DNA or RNA) and a protein coat, sometimes enclosed by an envelope composed of lipids, proteins, and carbohydrates. They multiply by using the host cell's synthesizing machinery to cause the synthesis of spe...
GENERAL CHARACTERISTICS OF VIRUSES Viruses contain a single type of nucleic acid (DNA or RNA) and a protein coat, sometimes enclosed by an envelope composed of lipids, proteins, and carbohydrates. They multiply by using the host cell's synthesizing machinery to cause the synthesis of specialized elements that can transfer the viral nucleic acid to other cells Uses: Genital Herpes simplex Primary disease Recurrent disease Mucocutaneous H. simplex H. simplex encephalitis (type-1 virus) H. simplex keratitis Herpes zoster Chickenpox Uses CMV- induced retinitis in patients with AIDS Amantadine Uses: Prophylaxis of influenza A2 during an epidemic or seasonal influenza Treatment of influenzal (A2) illness Reduction in fever, congestion, cough and quicker recovery Parkinsonism Uses: Zidovudine is used in HIV infected patients only in combination with at least 2 other ARV drugs Used for prevention of perinatal HIV-1 infection. TENOFOVIR Is the only nucleotide analogue, relatively newer Due to good tolerability profile, it is included in first line regimens Tenofovir containing regimens have been found as effective and less toxic as other first line regimens INTEGRASE INHIBITORS Dolutegravir Raltegravir Bictegravir Elvitegravir ANTIMICROBIAL RESISTANCE (AMR)